IceCure Medical Ltd(ICCM)

Medical - Devices · Caesarea, HA

$1.46-0.08 (-5.52%)

Delayed quote: Oct 6, 2026, 10:55 AM EDT

IceCure Medical (ICCM) EV/EBIT: History & Chart | TGMCharts

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T14:57:20.146Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:57:20.146Z.

Quote observation: 2026-10-06T14:55:05.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 3,276,737
Total debt · period ending 2026-06-30: 90,000
Cash · period ending 2026-06-30: 12,034,000
TTM operating income · period ending 2026-06-30: -21,959,000

FMP input reference: e4c5e5530b5f4ff9b2ae64c4564a307684e7c74323ce66c5db527ab157f5d0a0

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ICCM EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

ICCM Competitors' EV/EBIT Ratio

ICCM

IceCure Medical Ltd

Current

Market Cap

$3.28M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CVKD

Cadrenal Therapeutics, Inc. Common Stock

vs ICCM

Market Cap

$3.25M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AEMD

Aethlon Medical, Inc.

vs ICCM

Market Cap

$3.27M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBAI

MBody AI Ltd.

vs ICCM

Market Cap

$3.21M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MLEC

Moolec Science S.A.

vs ICCM

Market Cap

$3.40M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EVGN

Evogene Ltd.

vs ICCM

Market Cap

$3.46M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EOCN

Eocene Ltd.

vs ICCM

Market Cap

$3.47M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBIO

Mustang Bio, Inc.

vs ICCM

Market Cap

$3.49M

EV/EBIT Ratio

N/A

TTM Avg

1224.32x

3Y Avg

1224.32x

5Y Avg

1224.32x

BRTX

BioRestorative Therapies, Inc.

vs ICCM

Market Cap

$3.04M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NXL

Nexalin Technology, Inc.

vs ICCM

Market Cap

$3.58M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
IceCure Medical Ltd (ICCM)	$3.28M	N/A	N/A	N/A	N/A
Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›	$3.25M	N/A	N/A	N/A	N/A
Aethlon Medical, Inc. (AEMD)vs ›	$3.27M	N/A	N/A	N/A	N/A
MBody AI Ltd. (MBAI)vs ›	$3.21M	N/A	N/A	N/A	N/A
Moolec Science S.A. (MLEC)vs ›	$3.40M	N/A	N/A	N/A	N/A
Evogene Ltd. (EVGN)vs ›	$3.46M	N/A	N/A	N/A	N/A
Eocene Ltd. (EOCN)vs ›	$3.47M	N/A	N/A	N/A	N/A
Mustang Bio, Inc. (MBIO)vs ›	$3.49M	N/A	1224.32x	1224.32x	1224.32x
BioRestorative Therapies, Inc. (BRTX)vs ›	$3.04M	N/A	N/A	N/A	N/A
Nexalin Technology, Inc. (NXL)vs ›	$3.58M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

ICCM EV/EBIT Ratio Metrics

ICCM Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics